Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

President Donald Trump gathered dozens of hard-hat-clad coal miners around him in the White House East Room. He joked about ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved ...

COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

On the occasion of World No Tobacco Day, observed every year on May 31, leading healthcare experts across the country are ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

Tobacco smoke contains over 7,000 harmful chemicals, many of which are toxic and cancer-causing. Studies show that smokers ...

Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...

You are inviting a health disaster when you take a drag while sipping your morning tea. This toxic combo hits both your lungs and gut.